People with HIV (PWH) in long-term suppressive antiretroviral therapy (ART) are exhibiting increased prevalence of multi-systemic comorbidities compared to the general population. This includes cardiometabolic diseases, HIV-associated neurocognitive disorders, and non-HIV-associated malignancies. Chronic inflammation and microbial dysbiosis are among the major contributors to these major complications in PWH. The main objective of this study is to compare multi-systemic, proteomic profiling between virally suppressed PWH and healthy controls (HC).
This study included a discovery and validation cohort of in total ~900 virally suppressed PWH and ~220 age and sex-matched HC. Proximity extension assay technology is utilized for measurement of 1472 proteins from targeted proteomics platform across four different panels: inflammatory, cardiometabolic, neurology, and oncology. In the discovery cohort of PWH, the absolute concentration of acute-phase protein (hsCRP), microbial translocation marker (IFABP), and monocyte activation markers (sCD14, and sCD163) were measured by ELISA, and shotgun metagenomic sequencing from stool samples was done for identification of gut microbial species.
In the discovery and validation cohort, PWH displayed distinct systemic dysregulation of protein expression profile compared to HC (Fig.A and B). Out of 323 differentially expressed proteins (DEP), 313 proteins were upregulated in PWH and equally distributed across the four panels (Fig.C). Among the top proteins (fold-change >1.5) are the fatty acid binding protein group (FABP1 and 2), RBP2, and CES3. Enrichment analysis using publicly available bulk and single-cell transcriptomic data revealed that most of the DEP are originated from the intestine and lymphoid tissue (Fig.D). Pathway analysis of DEP demonstrated lipid and immune-related pathways, with the top pathway of lipid metabolism consisting of the FABP group. In addition, microbiome analysis showed positive influence of microbial species and pathways on DEP originated from enterocytes. Across panels, DEP were markedly associated with increased absolute concentrations of hsCRP, IFABP, sCD14, and sCD163.
Targeted proteomic analysis demonstrated a systemic upregulation of protein expression, of which most of the proteins originated from the intestine and lymphoid tissues. These upregulated proteins related significantly to markers of systemic inflammation and IFABP, confirming the known link between gut function and inflammation.